Dana Pharmaceuticals Private Limited, a active private limited company, was established on 07 August 1996 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239MH1996PTC101669. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.05 Cr and a paid-up capital of ₹3.81 Cr.
It upholds a compliant status. Employing 8 professional, Its leadership includes Suresh Sagarmal Parmar (Director), Abhai Sachidanand Attavar (Director), Gautam Hathiramani Ramesh (Director). Past directors included Sabita Ramesh Hathiramani, Suresh Sagarmal Parmar, Abhai Sachidanand Attavar. It holds ₹5.05 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 209,Bhaveshwar Complex,Vidyavihar (W), Mumbai-86., Mumbai, Maharashtra.
U24239MH1996PTC101669
101669
07 August 1996
₹4.05 Cr
₹3.81 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dana Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Sagarmal Parmar | Director | 02 Aug 2022 | Current |
| Abhai Sachidanand Attavar | Director | 02 Aug 2022 | Current |
| Gautam Hathiramani Ramesh | Director | 07 Aug 1996 | Current |
| Jacky Ramesh Hathiramani | Director | 07 Aug 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Director | 03 Aug 2022 | Past |
| Pramod Abcsdd | Director | 03 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dana Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.41% decrease. The company also saw a substantial improvement in profitability, with a 266.77% increase in profit. The company's net worth moved up by a moderate rise of 6.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Dana Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2010 | Indian Overseas Bank | ₹1.00 Cr | Open |
| 28 Mar 2008 | Indian Overseas Bank | ₹5.00 M | Open |
| 28 Mar 2008 | Indian Overseas Bank | ₹1.80 Cr | Open |
| 15 Oct 1997 | Indian Overseas Bank | ₹3.50 M | Open |
| 29 Sep 1997 | Indian Overseas Bank | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Dana Pharmaceuticals has a workforce of 8 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dana Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dana Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
The activity Dana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Suresh Sagarmal Parmar was appointed as a Director was appointed as a Director on 02 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
Abhai Sachidanand Attavar was appointed as a Director was appointed as a Director on 02 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity A charge with Indian Overseas Bank of Rs. 1.00 Cr registered on 26 Mar 2010 with Charge ID 10213566 was modified on 21 Dec 2017. was completed.
Progress on A charge with Indian Overseas Bank amounted to Rs. 1.00 Cr with Charge ID 10213566 was registered on 26 Mar 2010. was documented.
The CIN of Dana Pharmaceuticals Private Limited is U24239MH1996PTC101669.
Dana Pharmaceuticals Private Limited is headquartered at 209,Bhaveshwar Complex,Vidyavihar (W), Mumbai-86., Mumbai, Maharashtra.
Dana Pharmaceuticals Private Limited was incorporated on 07 August 1996.
The current directors of Dana Pharmaceuticals Private Limited are
The primary industry of Dana Pharmaceuticals Private Limited is Trade.
Dana Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dana Pharmaceuticals Private Limited is ₹4.05 Cr, and the paid-up capital is ₹3.81 Cr.
The compliance status of Dana Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX